Patent Applications published on Aug 15, 2024 - page 4

#901
US20240269143A1
Human necessities

COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND TYPE I PRMT INHIBITOR

#902
US20240269144A1
Human necessities

METHODS AND KITS FOR THE DETECTION OF MALIGNANCIES

#903
US20240269145A1
Human necessities

USE OF INDOLE COMPOUND AS INHIBITORS OF FERROPTOSIS

#904
US20240269146A1
Human necessities

USE OF PELABRESIB FOR TREATING ANEMIAS

#905 ✅ Patent 12,115,167 granted on 2024-10-15
US20240269147A1
Human necessities

Oral formulations of fasudil with ion exchange resin

#906
US20240269148A1
Human necessities

Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic Agents

#907
US20240269149A1
Human necessities

METHODS FOR INHIBITING MUSCLE ATROPHY

#908
US20240269150A1
Human necessities

WOUND TREATMENT COMPOSITION

#909
US20240269151A1
Human necessities

NASAL SLEEP FORMULATION

#910
US20240269152A1
Human necessities

NADES FORMULATIONS COMPRISING CANNABINOIDS

#911
US20240269153A1
Human necessities

BIOACTIVE BIPHASIC COMPOSITIONS

#912
US20240269154A1
Human necessities

CANNABIDIOL FOR USE IN THE TREATMENT OF PAIN RESULTING FROM AN INDOLEAMINE 2,3-DIOXYGENASE-1 (IDO1) RELATED DISEASE

#913
US20240269155A1
Human necessities

METHODS AND USES OF BORON COMPOUNDS IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIUM INFECTIONS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME

#914
US20240269156A1
Human necessities

DISULFIDE CONTAINING THERAPEUTICS

#915
US20240269157A1
Human necessities

COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING

#916
US20240269158A1
Human necessities

THERAPEUTIC AGENTS AND METHODS FOR TREATMENT OF BARTONELLOSIS

#917
US20240269159A1
Human necessities

NUTRITIONAL COMPOSITIONS FOR SKELETAL MUSCLE

#918
US20240269160A1
Human necessities

Use Of Citicoline In Regulating Respiratory Chain Function Related Protein Level And Preparing Drug For Preventing And Treating Respiratory Chain Dysfunction

#919
US20240269161A1
Human necessities

METHODS AND COMPOSITIONS FOR TAU REDUCTION GENE THERAPY

#920
US20240269162A1
Human necessities

Microdaily EMF Protects Against Oxidative and Inflammatory Damage, and Acute and Late Adverse Effects of EMF Radiation

#921
US20240269163A1
Human necessities

Treatment for Down Syndrome-Related Accelerated Aging

#922
US20240269164A1
Human necessities

A SOLID-GAS REACTION TO GENERATE NITROXYL (HNO) IN THE GAS PHASE

#923
US20240269165A1
Human necessities

FINE SILICON PARTICLE-CONTAINING PREVENTIVE OR THERAPEUTIC AGENT FOR DISEASES

#924
US20240269166A1
Human necessities

PAIN RELIEF COMPOSITION

#925
US20240269167A1
Human necessities

A MUCOSAL RE-EPITHELIALIZATION COMPOSITION

#926 ✅ Patent 12,109,228 granted on 2024-10-08
US20240269168A1
Human necessities

Treatment of neurodegenerative disease with sodium chlorite

#927
US20240269169A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM

#928
US20240269170A1
Human necessities

Treatment of Inflammatory Conditions or Diseases

#929
US20240269171A1
Human necessities

EPSTEIN-BARR VIRUS (EBV) ANTIGEN COMPOSITES AND DENDRITIC CELL (DC)-BASED VACCINE, AND USE THEREOF

#930
US20240269172A1
Human necessities

Methods and Compositions for Treatment of Intervertebral Disc Disease

#931
US20240269173A1
Human necessities

Biological Fluid Concentration Devices and Methods of Use

#932
US20240269174A1
Human necessities

ENHANCER FOR T-CELLS OR B-CELLS HAVING MEMORY FUNCTION, MALIGNANT TUMOR RECURRENCE INHIBITOR, AND INDUCER FOR INDUCING MEMORY FUNCTION IN T-CELLS OR B-CELLS

#933
US20240269175A1
Human necessities

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

#934
US20240269176A1
Human necessities

HETERODIMERIC FC DOMAIN ANTIBODIES

#935
US20240269177A1
Human necessities

Subject-Specific Tumor Inhibiting Cells and the Use Thereof

#936
US20240269178A1
Human necessities

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

#937
US20240269179A1
Human necessities

NEOANTIGENS AS TARGETS FOR IMMUNOTHERAPY

#938
US20240269180A1
Human necessities

PD-1 GENE-EDITED TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#939
US20240269181A1
Human necessities

METHOD FOR REGENERATING HUMORAL IMMUNITY SYSTEM AND USE THEREOF

#940
US20240269182A1
Human necessities

Modified Chimeric Antigen Receptor and Use thereof

#941
US20240269183A1
Human necessities

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#942
US20240269184A1
Human necessities

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#943
US20240269185A1
Human necessities

HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLS

#944
US20240269186A1
Human necessities

MULTILAYERED BLOOD PRODUCT

#945
US20240269187A1
Human necessities

ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS

#946
US20240269188A1
Human necessities

METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS

#947
US20240269189A1
Human necessities

EXTRACELLULAR VESICLE-ENRICHED SECRETOME COMPOSITION DERIVED FROM INDUCED PLURIPOTENT STEM CELL DERIVED-MICROGLIA AND METHODS OF USE THEREOF

#948
US20240269190A1
Human necessities

CELLULAR COMPOSITIONS FOR TREATING BACK PAIN

#949
US20240269191A1
Human necessities

OCULAR SYMPTOM-IMPROVING AGENT AND METHOD FOR IMPROVING OCULAR SYMPTOM

#950
US20240269192A1
Human necessities

FIBROBLAST BASED THERAPEUTICS OF AMYOTROPHIC LATERAL SCLEROSIS

#951
US20240269193A1
Human necessities

STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES

#952
US20240269194A1
Human necessities

COMPOSITIONS AND METHODS FOR ISLET CELL TRANSPLANTS

#953
US20240269195A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO POOLED FETAL SUPPORT TISSUE

#954
US20240269196A1
Human necessities

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

#955
US20240269197A1
Human necessities

INSULIN-SENSITIZING AGENT AND BUTYRATE-PRODUCING BACTERIUM

#956
US20240269198A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES

#957
US20240269199A1
Human necessities

COMPOSITIONS FOR CONTROL OF HUMAN AND ANIMAL PARASITIC NEMATODES AND METHODS OF USE

#958
US20240269200A1
Human necessities

NOVEL LACTOBACILLUS SP. STRAIN AND USE THEREOF

#959
US20240269201A1
Human necessities

LACTOBACILLUS ACIDOPHILUS-DERIVED VESICLES AND USE THEREOF

#960
US20240269202A1
Human necessities

USE OF LACTOBACILLUS FERMENTUM STRAIN AND REGULATORY T CELLS FOR COMBINATION THERAPY FOR PREVENTION OR TREATMENT OF METABOLIC DISEASES

#961
US20240269203A1
Human necessities

ONCOLYTIC VIRUS AND USES THEREOF

#962
US20240269204A1
Human necessities

COMPOSITION FOR ALLEVIATING SKIN DAMAGE CAUSED BY HYPOXIA CONTAINING SACCHAROMYCES CEREVISIAE STRAIN

#963
US20240269205A1
Human necessities

MULTI-VIRUS ANTI-INFECTIVITY AND PRO-IMMUNITY ASSEMBLY

#964
US20240269206A1
Human necessities

AMANITA MUSCARIA EXTRACTS AND COMPOUNDS AND THEIR BENEFICIAL AND THERAPEUTIC USE

#965
US20240269207A1
Human necessities

Cannabis Parthenogenesis Practical Resin And Fiber Cultivation Ptocess

#966
US20240269208A1
Human necessities

METHOD FOR PRODUCING PLANT-DERIVED COLLAGEN PEPTIDE MIXTURE

#967
US20240269209A1
Human necessities

HEMP COMPOSITIONS AND METHODS OF MAKING THE SAME

#968
US20240269210A1
Human necessities

METHOD FOR ENHANCING BIOLOGICAL ENERGY WITH EXTRACT

#969
US20240269211A1
Human necessities

Pharmaceutical Composition For Preventing And Treating Inflammatory Bowel Disease

#970
US20240269212A1
Human necessities

HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS

#971 ✅ Patent 12,311,007 granted on 2025-05-27
US20240269213A1
Human necessities

Herbal products and methods for tetrahydrocannabinol (THC) detoxification

#972
US20240269214A1
Human necessities

SUBSTANCE HAVING HIGH ACTIVITY AND HIGH SAFETY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN DRUG

#973
US20240269215A1
Human necessities

NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION

#974
US20240269216A1
Human necessities

OLIVE DERIVED CELL CULTURE AND METHODS FOR PREPARING AND USING THE SAME

#975
US20240269217A1
Human necessities

FORSYTHIA SUSPENSA LEAF EXTRACT AND USE THEREOF FOR INCREASING ABUNDANCE OF AKK IN INTESTINAL TRACTS

#976
US20240269218A1
Human necessities

COMPOSITION FOR PROMOTING AND IMPROVING SLEEP AND BEVERAGE CONTAINING SAME, AND MANUFACTURING METHOD THEREOF

#977
US20240269219A1
Human necessities

PHARMACEUTICAL COMPOSITION AND ITS ANTIVIRAL USE

#978
US20240269220A1
Human necessities

USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS

#979
US20240269221A1
Human necessities

A SYNERGISTIC PHYTOEXTRACT FORMULATION FOR ANTI-INFLAMMATORY ACTION

#980
US20240269222A1
Human necessities

COMPOSITION FOR RESPIRATORY DISEASES

#981
US20240269223A1
Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT FOR ACUTE RENAL FAILURE

#982
US20240269224A1
Human necessities

STABLE READY TO DILUTE COMPOSITION OF CARFILZOMIB

#983 ✅ Patent 12,280,089 granted on 2025-04-22
US20240269225A1
Human necessities

Dry powder formulation of caveolin-1 peptides and methods of use thereof

#984
US20240269226A1
Human necessities

COMBINATION THERAPY WITH SEMAX AND CANNABIDIOL

#985
US20240269227A1
Human necessities

CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF

#986
US20240269228A1
Human necessities

SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM

#987
US20240269229A1
Human necessities

NOVEL LIPOPEPTIDE FORMULATION

#988
US20240269230A1
Human necessities

CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS FOR MS THERAPY

#989 ✅ Patent 12,251,421 granted on 2025-03-18
US20240269231A1
Human necessities

Methods for treating cancers using fat specific protein 27 (FSP27) compositions

#990
US20240269232A1
Human necessities

A MODIFIED HLA-B57 WITH INCREASED EXPRESSION LEVELS

#991
US20240269233A1
Human necessities

METHODS FOR TREATMENT OF OSTEOARTHRITIS

#992
US20240269234A1
Human necessities

METHOD OF TREATING CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCT AND LEUKOENCEPHALOPATHY (CADASIL)

#993
US20240269235A1
Human necessities

INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE

#994
US20240269236A1
Human necessities

METHODS OF TREATING AGE-RELATED FRAILTY WITH INTERLEUKIN-6

#995
US20240269237A1
Human necessities

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

#996
US20240269238A1
Human necessities

Therapeutic Regimens and Methods for Reducing Body Weight in a Subject with Fatty Liver Disease using a GLP-1R and GCGR Agonist

#997 ✅ Patent 12,150,974 granted on 2024-11-26
US20240269239A1
Human necessities

Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells

#998
US20240269240A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS OR FACILITATING HAIR GROWTH

#999
US20240269241A1
Human necessities

GENE THERAPY OF HEMOPHILIA A USING VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION

#1000
US20240269242A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE

#1001
US20240269243A1
Human necessities

ALKALINE PHOSPHATASE FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISORDER

#1002
US20240269244A1
Human necessities

Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1

#1003
US20240269245A1
Human necessities

NUCLEIC ACID MOLECULES ENCODING CLOSTRIDIUM HISTOLYTICUM COLLAGENASE I AND METHODS OF PRODUCING THE SAME

#1004
US20240269246A1
Human necessities

METHODS FOR TREATING CERVICAL DYSTONIA

#1005 ✅ Patent 12,274,740 granted on 2025-04-15
US20240269247A1
Human necessities

Microbiome protection from oral antibiotics

#1006
US20240269248A1
Human necessities

POLYNUCLEOTIDES ENCODING METHYLMALONYL-COA MUTASE FOR THE TREATMENT OF METHYLMALONIC ACIDEMIA

#1007
US20240269249A1
Human necessities

METHODS OF TREATING ATOPIC DERMATITIS

#1008
US20240269250A1
Human necessities

COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION

#1009
US20240269251A1
Human necessities

GENETIC SWITCHES AND THEIR USE IN TREATING CANCER

#1010
US20240269252A1
Human necessities

COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE

#1011
US20240269253A1
Human necessities

DNA VACCINE FOR USE IN THE THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF TUMOR DISEASES

#1012
US20240269254A1
Human necessities

Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or Agonist

#1013
US20240269255A1
Human necessities

HPV INFECTIOUS DISEASE VACCINE

#1014
US20240269256A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN BINDING PROTEINS

#1015
US20240269257A1
Human necessities

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

#1016
US20240269258A1
Human necessities

MULTIVALENT INFLUENZA VACCINES

#1017
US20240269259A1
Human necessities

RABIES VIRUS VACCINE

#1018
US20240269260A1
Human necessities

mRNA-Based Vaccine Composition for Inducing Immune Response Against HIV and HPV

#1019
US20240269261A1
Human necessities

EXPRESSION OF SARS-COV PROTEINS, NUCLEIC ACID CONSTRUCTS, VIRUS LIKE PROTEINS (VLPS) AND METHODS RELEVANT THERETO

#1020
US20240269262A1
Human necessities

METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES

#1021
US20240269263A1
Human necessities

IMMUNOMODULATORY COMPOSITIONS AND RELATED METHODS

#1022
US20240269264A1
Human necessities

HUMAN CORONAVIRUS 229E DERIVED PEPTIDES

#1023
US20240269265A1
Human necessities

Peptide VLP-Based Vaccines

#1024
US20240269266A1
Human necessities

BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE

#1025
US20240269267A1
Human necessities

SYNTHETIC DNA VACCINE IMMUNOGENIC IMPROVEMENTS

#1026
US20240269268A1
Human necessities

TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES

#1027
US20240269269A1
Human necessities

Self-Assembling Nanoparticles

#1028
US20240269270A1
Human necessities

COVID-19 VACCINES WITH TOCOPHEROL-CONTAINING SQUALENE EMULSION ADJUVANTS

#1029
US20240269271A1
Human necessities

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS

#1030
US20240269272A1
Human necessities

VACCINE COMPOSITION COMPRISING ENCODED ADJUVANT

#1031
US20240269273A1
Human necessities

USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

#1032
US20240269274A1
Human necessities

TREATMENT FOR BONE DISEASES

#1033 ✅ Patent 12,246,065 granted on 2025-03-11
US20240269275A1
Human necessities

Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen

#1034
US20240269276A1
Human necessities

SPECIFIC BINDING PROTEIN TARGETING PD-L1 AND CD73

#1035
US20240269277A1
Human necessities

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

#1036
US20240269278A1
Human necessities

ANTI-CD47 ANTIBODY FOR COMBINED TREATMENT OF BLOOD TUMOR

#1037
US20240269279A1
Human necessities

PHARMACEUTICAL FORMULATION CONTAINING AN ANTI-IgE ANTIBODY

#1038
US20240269280A1
Human necessities

PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES

#1039
US20240269281A1
Human necessities

CAR-T CELL THERAPY FOR TRIPLE NEGATIVE BREAST CANCER

#1040
US20240269282A1
Human necessities

Methods for the Treatment of Cancer, Inflammatory Diseases and Autoimmune Diseases

#1041 ✅ Patent 12,133,890 granted on 2024-11-05
US20240269283A1
Human necessities

Antigen-binding polypeptide targeting B7H3 and application thereof

#1042
US20240269284A1
Human necessities

METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T CELLS

#1043
US20240269285A1
Human necessities

POLYPEPTIDES TARGETING CD70-POSITIVE CANCERS

#1044
US20240269286A1
Human necessities

METHODS AND COMPOSITIONS FOR DECREASING CHRONIC PAIN

#1045
US20240269287A1
Human necessities

MICROBUBBLE-ASSISTED ULTRASOUND-GUIDED THERAPY

#1046
US20240269288A1
Human necessities

NON-CONTACT LITHOTRIPSY USING PHOTONIC NANOPARTICLES

#1047 ✅ Patent 12,350,338 granted on 2025-07-08
US20240269289A1
Human necessities

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#1048
US20240269290A1
Human necessities

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

#1049
US20240269291A1
Human necessities

Transcutol-Polyol-Active Agent Ternary Complex, Pharmaceutical Composition for Topical Use Comprising Same, Method for Obtaining Same and Use Thereof in Different Pathologies

#1050
US20240269292A1
Human necessities

INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE

#1051
US20240269293A1
Human necessities

PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF

#1052 ✅ Patent 12,280,115 granted on 2025-04-22
US20240269294A1
Human necessities

Cytokine-bisphosphonate conjugates

#1053
US20240269295A1
Human necessities

C-MET TARGETED APTAMER DRUG CONJUGATE AND METHOD FOR TREATING TUMOR

#1054
US20240269296A1
Human necessities

ANTIOXIDANT NUCLEOLIPID PRODRUG, PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION THEREOF, AND THERAPEUTIC USES THEREOF

#1055 ✅ Patent 12,115,222 granted on 2024-10-15
US20240269297A1
Human necessities

Compositions and methods for improving the solubility of erectile dysfunction therapeutics

#1056
US20240269298A1
Human necessities

PHOSPHONYL DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF

#1057
US20240269299A1
Human necessities

POLYETHYLENE GLYCOL-DRUG CONJUGATE AND USE THEREOF

#1058
US20240269300A1
Human necessities

METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS

#1059
US20240269301A1
Human necessities

METHOD FOR INITIATING POLYMERIZATION OF AMINO ACID N-CARBOXYANHYDRIDES IN AQUEOUS PHASE

#1060
US20240269302A1
Human necessities

NANOPARTICLE COMPRISING PEPTIDE-LIPID CONJUGATE FOR DELIVERING OLIGONUCLEOTIDE INTO TARGET CELL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#1061
US20240269303A1
Human necessities

CELL TARGETING CONSTRUCTS AND USES THEREOF

#1062
US20240269304A1
Human necessities

BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

#1063
US20240269305A1
Human necessities

STING AGONIST SUITABLE AS PAYLOAD OF ANTIBODY DRUG CONJUGATE

#1064
US20240269306A1
Human necessities

B7H4-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

#1065
US20240269307A1
Human necessities

ANTI-NECTIN-4 ANTIBODY AND ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE, AND MEDICINAL USE THEREOF

#1066
US20240269308A1
Human necessities

PRODRUGS OF TOPOISOMERASE I INHIBITOR FOR ADC CONJUGATIONS AND METHODS OF USE THEREOF

#1067
US20240269309A1
Human necessities

CAMPTOTHECIN ANALOGUES, CONJUGATES AND METHODS OF USE

#1068
US20240269310A1
Human necessities

THERAPEUTIC TARGETING OF CADHERIN 11 IN CANCER

#1069
US20240269311A1
Human necessities

REGIOSELECTIVE CONJUGATE OF ANTIBODY AND FUNCTIONAL SUBSTANCE OR SALT THEREOF, AND ANTIBODY DERIVATIVE AND COMPOUND USED IN PRODUCTION OF THE SAME OR SALTS THEREOF

#1070
US20240269312A1
Human necessities

ANTIBODY DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#1071
US20240269313A1
Human necessities

CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG

#1072
US20240269314A1
Human necessities

PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF

#1073
US20240269315A1
Human necessities

DRUG CONJUGATE AND USE THEREOF

#1074
US20240269316A1
Human necessities

NUCLEIC ACID SENSOR AGONIST COMPOSITIONS AND USES THEREOF

#1075
US20240269317A1
Human necessities

TARGETED ENCAPSULATION STRATEGIES FOR TREATMENT MODALITIES

#1076
US20240269318A1
Human necessities

NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF

#1077
US20240269319A1
Human necessities

METHODS FOR ASSEMBLING SCAVENGING PARTICLES

#1078
US20240269320A1
Human necessities

EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE

#1079
US20240269321A1
Human necessities

PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY

#1080
US20240269322A1
Human necessities

ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF

#1081
US20240269323A1
Human necessities

DNA Vector Delivery Using Lipid Nanoparticles

#1082
US20240269324A1
Human necessities

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of ANG, ANGPT1, VEGFA, FGF1, HIF1a, HGF, SDF1, KLK4, PDGFC, PROK1, and PROK2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-ANG, or Escherichia coli strain SCS110-AF/VTvaf17-ANGPT1, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-FGF

#1083 ✅ Patent 12,257,318 granted on 2025-03-25
US20240269325A1
Human necessities

Polynucleotide compositions, related formulations, and methods of use thereof

#1084
US20240269326A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS

#1085
US20240269327A1
Human necessities

COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION

#1086
US20240269328A1
Human necessities

RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF

#1087
US20240269329A1
Human necessities

GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY

#1088 ✅ Patent 12,290,576 granted on 2025-05-06
US20240269330A1
Human necessities

Manufacturing of dimeric contrast agents

#1089
US20240269331A1
Human necessities

FLUID-BASED POWDER CONVEYANCE SYSTEMS AND METHODS FOR MEDICAL DEVICE CLEANING AND/OR LUMEN CLEANING

#1090
US20240269332A1
Human necessities

METHODS OF DISARMING VIRUSES USING REACTIVE GAS

#1091
US20240269333A1
Human necessities

POLYCATIONIC ANTIVIRAL COUNTERION APPARATUS AND METHOD OF CONTROL THEREOF

#1092
US20240269334A1
Human necessities

Method of Cleaning Region in Industrial Environment, Control System and Cleaning System

#1093 ✅ Patent 12,290,618 granted on 2025-05-06
US20240269335A1
Human necessities

Scent dispensers/absorbers and scent cartridges therefor

#1094
US20240269336A1
Human necessities

SYSTEMS, METHODS, AND APPARATUSES FOR IMPLEMENTING OLFACTORY DELIVERY IN VIRTUALIZED ENVIRONMENTS USING AN OLFACTORY DELIVERY ENGINE

#1095
US20240269337A1
Human necessities

METHOD AND SYSTEM FOR COATING FILTER MEDIA

#1096
US20240269338A1
Human necessities

System and Method for Disinfection with Ultraviolet Light

#1097
US20240269339A1
Human necessities

DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY

#1098
US20240269340A1
Human necessities

MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS

#1099
US20240269341A1
Human necessities

HEMOSTATIC COMPOSITIONS AND METHODS OF MAKING THEREOF

#1100
US20240269342A1
Human necessities

GREEN SYNTHESIS OF Ag-Ni BIMETALLIC NANOPARTICLE-INCORPORATED PVA/PAA HYDROGELS WITH ANTIMICROBIAL PROPERTIES

#1101
US20240269343A1
Human necessities

USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION

#1102
US20240269344A1
Human necessities

POROUS STRUCTURE AND METHOD FOR PRODUCING POROUS STRUCTURE

#1103
US20240269345A1
Human necessities

BIODEGRADABLE IMPLANTS WITH ANTICORROSIVE COATINGS CONTAINING SILK FIBROIN

#1104
US20240269346A1
Human necessities

Implantable Device Comprising External Mobilisation Means for the Formation of Articular Cartilage

#1105
US20240269347A1
Human necessities

BIOADHESIVE FOR CORNEAL REPAIR

#1106
US20240269348A1
Human necessities

Tissue-Engineered Rostral Migratory Stream for Neuronal Replacement

#1107
US20240269349A1
Human necessities

SOL-GEL CONVERSION OVER TIME OF 6-ARM PEG HYDROGEL

#1108
US20240269350A1
Human necessities

IMPLANTABLE MATRIX FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

#1109
US20240269351A1
Human necessities

NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY

#1110
US20240269352A1
Human necessities

MINIATURIZED HYDROGEL AND USES THEREOF

#1111
US20240269353A1
Human necessities

NITRIC OXIDE-RELEASING DEVICES

#1112
US20240269354A1
Human necessities

CARDIOTHORACIC DRAINAGE DEVICE

#1113
US20240269355A1
Human necessities

BREAST PUMP ACCESSORY SYSTEM

#1114
US20240269356A1
Human necessities

MEDICAL TREATMENT SYSTEM AND METHODS USING A PLURALITY OF FLUID LINES

#1115
US20240269357A1
Human necessities

FLUID TREATMENT METHOD AND FLUID TREATMENT DEVICE

#1116 ✅ Patent 12,220,507 granted on 2025-02-11
US20240269358A1
Human necessities

Blood treatment systems and methods

#1117 ✅ Patent 12,178,944 granted on 2024-12-31
US20240269359A1
Human necessities

Optical sensor for determining a dialysis dose

#1118 ✅ Patent 12,290,619 granted on 2025-05-06
US20240269360A1
Human necessities

Method, facility and tank for the manufacture of a liquid acid concentrate used for hemodialysis machines

#1119
US20240269361A1
Human necessities

BLOOD PURIFICATION APPARATUS

#1120 ✅ Patent 12,133,946 granted on 2024-11-05
US20240269362A1
Human necessities

Durable, multi-use peritoneal dialysis cycler using disinfection

#1121
US20240269363A1
Human necessities

ONLINE FLUID GENERATING PERITONEAL DIALYSIS CYCLER

#1122
US20240269364A1
Human necessities

Medical Treatment Systems, Methods, and Apparatuses Using a Plurality of Fluid Lines

#1123
US20240269365A1
Human necessities

EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS

#1124
US20240269366A1
Human necessities

Drainage System Including Actuation Device For Providing A Negative Pressure For Draining And Collecting Bodily Fluids

#1125
US20240269367A1
Human necessities

PERFUSION STATE DETECTION METHOD, PERFUSION STATE DETECTION APPARATUS, AND ENDOSCOPE SYSTEM

#1126
US20240269368A1
Human necessities

FLUID MANAGEMENT DEVICE AND SYSTEM

#1127 ✅ Patent 12,329,896 granted on 2025-06-17
US20240269369A1
Human necessities

SYSTEMS AND METHODS FOR EXTENDING OPERATIONAL TIME OF NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES

#1128
US20240269370A1
Human necessities

ENEMA DEVICE, AND A DELIVERY CONTAINER FOR USE IN SAID ENEMA DEVICE

#1129
US20240269371A1
Human necessities

LIQUID DISPENSER FOR NASAL APPLICATIONS

#1130
US20240269372A1
Human necessities

DRUG CARTRIDGE, DRUG DELIVERY DEVICES, AND METHODS FOR PREPARING THEREOF

#1131 ✅ Patent 12,303,662 granted on 2025-05-20
US20240269373A1
Human necessities

Injection devices and systems and methods for using them

#1132 ✅ Patent 12,121,695 granted on 2024-10-22
US20240269374A1
Human necessities

Integrated cartridge assembly for administration of drugs

#1133
US20240269375A1
Human necessities

Bolus Delivery Device

#1134
US20240269376A1
Human necessities

NEEDLE INSERTION MECHANISM FOR AN INJECTION OR INFUSION DEVICE

#1135
US20240269377A1
Human necessities

MEDICAL FLUID DELIVERY DEVICE PROGRAMMING

#1136
US20240269378A1
Human necessities

MEDICATION DELIVERY SYSTEM, PATCH PUMP AND MEDICAMENT DELIVERY DEVICE

#1137
US20240269379A1
Human necessities

DRUG DELIVERY INSERTION APPARATUSES AND SYSTEM

#1138
US20240269380A1
Human necessities

SAFETY DEVICE FOR DRUG DELIVERY SYSTEM

#1139
US20240269381A1
Human necessities

CHAIN COMPOSITION PREPARATION APPARATUS AND PREPARATION METHOD

#1140
US20240269382A1
Human necessities

CLOSED-LOOP HOME DIURETIC THERAPY SYSTEM

#1141
US20240269383A1
Human necessities

Methods of Incorporating CGM Data Into Diabetes Therapy

#1142
US20240269384A1
Human necessities

SEPSIS MONITOR

#1143
US20240269385A1
Human necessities

APPARATUS FOR FILLING A FLUID DELIVERY

#1144
US20240269386A1
Human necessities

REUSABLE INJECTION APPARATUS AND METHOD

#1145
US20240269387A1
Human necessities

CONNECTED HEALTH PLATFORM INCLUDING NEEDLE-FREE INJECTOR SYSTEM

#1146
US20240269388A1
Human necessities

Method of Making a Low-Silicone Oil System for a Medical Injection Device

#1147
US20240269389A1
Human necessities

Syringe Plunger With Dynamic Seal

#1148
US20240269390A1
Human necessities

DRUG DELIVERY DEVICE AND METHOD FOR OPERATING A DRUG DELIVERY DEVICE

#1149 ✅ Patent 12,370,323 granted on 2025-07-29
US20240269391A1
Human necessities

INJECTION DEVICE AND INJECTION UNIT

#1150
US20240269392A1
Human necessities

Needle Shield Assembly for a Syringe

#1151
US20240269393A1
Human necessities

Systems, Methods and Devices for Portable Medication Delivery

#1152
US20240269394A1
Human necessities

DEVICE FOR PROVIDING CONTAINER CLOSURE INTEGRITY AND METHODS OF USE THEREOF

#1153
US20240269395A1
Human necessities

INJECTION NEEDLE

#1154
US20240269396A1
Human necessities

MICRO ATOMIZATION DEVICE

#1155
US20240269397A1
Human necessities

DROPLET DELIVERY DEVICE WITH PUSH EJECTION

#1156
US20240269398A1
Human necessities

SPRAY HEAD FOR A DEVICE FOR DISPENSING A FLUID PRODUCT

#1157
US20240269399A1
Human necessities

ON-DEMAND, PORTABLE CONVECTION VAPORIZER

#1158
US20240269400A1
Human necessities

AEROSOL DELIVERY DEVICE INCLUDING A MOVEABLE CARTRIDGE AND RELATED ASSEMBLY METHOD

#1159
US20240269401A1
Human necessities

MIST INHALER DEVICES FOR DELIVERING MEDICAL DRUGS

#1160
US20240269402A1
Human necessities

CARTRIDGE FOR E-VAPING DEVICE WITH OPEN-MICROCHANNELS

#1161
US20240269403A1
Human necessities

MANIFOLD FOR RESPIRATORY THERAPY APPARATUS

#1162
US20240269404A1
Human necessities

UNCONSCIOUS MASK REMOVAL DETECTION AND ADAPTIVE ALERTING BY USING RESPIRATORY AND BEHAVIOURAL SIGNALS

#1163 ✅ Patent 12,208,201 granted on 2025-01-28
US20240269405A1
Human necessities

Breathing control using high flow respiration assistance

#1164
US20240269406A1
Human necessities

EMERGENCY VENTILATOR SYSTEM

#1165
US20240269407A1
Human necessities

SYSTEMS AND METHODS FOR MALIGNANT HYPERTHERMIA VAPORIZER USE PREVENTION

#1166
US20240269408A1
Human necessities

SYSTEMS AND METHODS FOR SUPPLEMENTAL OXYGEN DELIVERY

#1167
US20240269409A1
Human necessities

SYSTEMS AND METHODS TO DETERMINE THE CONFIGURATION OF RESPIRATORY THERAPY SYSTEMS

#1168
US20240269410A1
Human necessities

A MEDICAL VENTILATOR SYSTEM AND A METHOD FOR PREDICTING TRANSIENT STATES OF A VENTILATED PATIENT UPON CHANGES IN MECHANICAL VENTILATOR SETTINGS

#1169
US20240269411A1
Human necessities

ENDOTRACHEAL TUBE WITH ULTRASOUND-VISIBLE DOUBLE CUFF

#1170
US20240269412A1
Human necessities

Intubation Stylet and Related Methods

#1171
US20240269413A1
Human necessities

MASK ASSEMBLY FOR USE WITH A CONTINUOUS POSITIVE AIRWAY PRESSURE MACHINE

#1172 ✅ Patent 12,343,475 granted on 2025-07-01
US20240269414A1
Human necessities

LINER AND RETAINING MEMBER FOR USE WITH RESPIRATORY MASK

#1173 ✅ Patent 12,208,208 granted on 2025-01-28
US20240269415A1
Human necessities

Mask system with shroud and vent holes

#1174
US20240269416A1
Human necessities

PATIENT INTERFACE AND COMPONENTS THEREOF

#1175
US20240269417A1
Human necessities

RESPIRATORY MASK

#1176
US20240269418A1
Human necessities

SAMPLE GAS FILTER FOR A THERAPEUTIC GAS DELIVERY DEVICE

#1177 ✅ Patent 12,053,584 granted on 2024-08-06
US20240269419A1
Human necessities

COUPLER

#1178
US20240269420A1
Human necessities

A BREATHING ASSEMBLY

#1179
US20240269421A1
Human necessities

VENTILATION SYSTEM WITH IMPROVED VALVING

#1180
US20240269422A1
Human necessities

DEVICE AND SYSTEM FOR PPV AND CPAP TREATMENT

#1181
US20240269423A1
Human necessities

RESPIRATORY THERAPY DEVICES

#1182 ✅ Patent 12,144,931 granted on 2024-11-19
US20240269424A1
Human necessities

System and method for producing sound and light for therapeutic effect

#1183
US20240269425A1
Human necessities

FLAVOR INHALER OR AEROSOL GENERATING DEVICE, AND CONTROL METHOD THEREFOR AND PROGRAM THEREFOR

#1184
US20240269426A1
Human necessities

Intermittent Catheters and Methods

#1185
US20240269427A1
Human necessities

Urinary Catheter Container

#1186
US20240269428A1
Human necessities

MEDICAL DEVICE FOR ULTRASOUND-ASSISTED DRUG DELIVERY

#1187
US20240269429A1
Human necessities

FLEXIBLE RADIOPAQUE CATHETER SHAFT

#1188
US20240269430A1
Human necessities

PATTERNED TIE LAYER FOR CATHETER PERFORMANCE OPTIMIZATION

#1189
US20240269431A1
Human necessities

DEVICES AND METHODS FOR A VARIABLY LOCKING SYRINGE ASSEMBLY

#1190
US20240269432A1
Human necessities

Blood Draw Connector for Open Peripheral Intravenous Catheters

#1191
US20240269433A1
Human necessities

CATHETER INSERTION DEVICE AND METHOD OF INSERTING A CATHETER

#1192
US20240269434A1
Human necessities

ADJUSTABLE SELF-ANCHORING CATHETERS AND METHODS OF USE

#1193
US20240269435A1
Human necessities

Medical Device Centering Device

#1194
US20240269436A1
Human necessities

CATHETER INSERTION DEVICE

#1195
US20240269437A1
Human necessities

CATHETER ASSEMBLY WITH NEEDLE TIP PROTECTION AND PASSIVE BLOOD CONTROL

#1196
US20240269438A1
Human necessities

VASCULAR INTERVENTION PROCEDURE DEVICE

#1197
US20240269439A1
Human necessities

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS

#1198
US20240269440A1
Human necessities

SYSTEM AND METHODS FOR TREATING MVO

#1199
US20240269441A1
Human necessities

Balloon For Catheter And Balloon Catheter

#1200 ✅ Patent 12,285,579 granted on 2025-04-29
US20240269442A1
Human necessities

Sheath stepwise dilation